This analysis is underpinned by strong and robust clinical evidence from both randomised and observational studies.Ĭlosed surgical incisions cost-effectiveness diabetes dressing single-use negative pressure wound therapy surgical site complications wound wound healing. Patients at higher risk should be targeted first as they benefit more from sNPWT. Our findings suggest that the use of sNPWT following closed surgical incisions saves cost when compared with standard care because of reduced incidence of SSC. Negative pressure wound therapy (NPWT) is a wound treatment involving the application of subatmospheric pressure to remove excessive exudate and prevent infection while changing dressings and promoting healing 1, 2, 3, 4. We conducted both one-way and probabilistic sensitivity analysis, and the results suggested that this conclusion is robust. There were more savings when higher-risk patients with diabetes, or a BMI ≥30kg/m 2 or an ASA≥3 were considered. SNPWT resulted in better clinical outcomes and overall savings of £105 per patient from the UK perspective and $637 per patient from the US perspective. A sensitivity analysis was also conducted. We conducted subgroup analysis of patients with diabetes, an American Society of Anesthesiologists (ASA) score ≥3 and body mass index (BMI) ≥30kg/m 2. The PICO Single Use Negative Pressure Wound Therapy System, by Smith and Nephew, is a small portable pump meant to extract wound fluid (exudate) when normal wound dressing and bandages are not adequate for optimum wound closure and healing. Cost data were sourced from published literature, NHS reference costs and Centers for Medicare and Medicaid Services. We modelled complications avoided (surgical site infection (SSI) and dehiscence) using data from a recently published meta-analysis. We sought to evaluate the cost-effectiveness of sNPWT compared with standard care in reducing SSCs following closed surgical incisions.Ī decision analytic model was developed to explore the total costs and health outcomes associated with the use of the interventions in patients following vascular, colorectal, cardiothoracic, orthopaedic, C-section and breast surgery from the UK National Health Service (NHS) and US payer perspective over a 12-week time horizon. However, there is little health economic evidence to support its widespread use. Negative pressure wound therapy (NPWT) promotes healing by evenly applying negative pressure on the surface of the wound. The authors concluded that RCTs comparing healing, costs of care, patient pain, and quality-of-life outcomes of this treatment to non-gauze type dressings and. Single-use negative pressure wound therapy (sNPWT) following closed surgical incisions has a demonstrable effect in reducing surgical site complications (SSC).
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |